Are patients with chronic obstructive pulmonary disease at a greater risk for the development of autoimmune thyroiditis as an adverse event of immunotherapy in non-small cell lung cancer treatment?

Are patients with chronic obstructive pulmonary disease at a greater risk for the development of autoimmune thyroiditis as an adverse event of immunotherapy in non-small cell lung cancer treatment?

IntroductionImmunotherapy has made a significant improvement in the treatment of patients with non-small cell lung cancer (NSCLC). It has a role in boosting the immune system, so it can fight cancer cells. Sometimes, this mechanism can lead to an overstimulation or misdirection of immune response, s...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrej Zecevic, Ana Blanka-Protic, Aleksandar Jandric, Tatjana Adzic-Vukicevic
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Pathology and Oncology Research
Subjects:
chronic obstructive lung disease
non-small cell lung cancer
immunotherapy
thyroiditis
adverse event
Online Access:https://www.por-journal.com/articles/10.3389/pore.2025.1612022/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.por-journal.com/articles/10.3389/pore.2025.1612022/full

Similar Items